
Royalty Pharma PLC is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The company assembles a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry's therapies, which includes royalti... Royalty Pharma PLC is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The company assembles a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry's therapies, which includes royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica, Astellas and Pfizer's Xtandi, Biogen's Tysabri, Johnson & Johnson's Tremfya, Gilead's Trodelvy, Merck's Januvia, Novartis' Promacta, Vertex's Kalydeco, Orkambi, Symdeko and Trikafta, and ten development-stage product candidates. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.92 | 2.84038283421 | 32.39 | 33.66 | 32 | 5205310 | 32.56107425 | CS |
4 | 2.7 | 8.82064684744 | 30.61 | 33.66 | 30.61 | 4543980 | 31.92727462 | CS |
12 | 6.71 | 25.2255639098 | 26.6 | 33.66 | 24.05 | 3776442 | 29.04560313 | CS |
26 | 5.76 | 20.9074410163 | 27.55 | 33.66 | 24.05 | 2995489 | 28.23821461 | CS |
52 | 3.4 | 11.3674356403 | 29.91 | 33.66 | 24.05 | 2872755 | 28.19771137 | CS |
156 | -5.69 | -14.5897435897 | 39 | 44.75 | 24.05 | 2331956 | 32.35460274 | CS |
260 | 32.64 | 4871.64179104 | 0.67 | 57.5 | 0.67 | 2267475 | 35.98387162 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관